Boston Scientific to participate in TD Cowen's 46th Annual Health Care Conference

Rhea-AI Summary

Boston Scientific (NYSE: BSX) will participate in TD Cowen's 46th Annual Health Care Conference on Tuesday, March 3, 2026. Mike Mahoney, chairman and CEO, and Kenneth Stein, M.D., senior VP and global chief medical officer, will join a 30-minute Q&A at ~9:10 a.m. ET.

A live webcast and replay will be available at the company investor website, with the replay posted about one hour after the session ends.

Key Figures

Conference edition: 46th Annual Conference date: March 3, 2026 Session duration: 30 minutes +2 more

5 metrics

Conference edition 46th Annual TD Cowen Health Care Conference

Conference date March 3, 2026 Scheduled participation at TD Cowen conference

Session duration 30 minutes Q&A session with host analyst

Session time 9:10 a.m. ET Start time for Q&A session

Replay timing 1 hour Approximate delay before webcast replay is available

Market Reality Check

Price: $74.73 Vol: Volume 14122414 is at 0.6...

low vol

$74.73 Last Close

Volume Volume 14122414 is at 0.65x the 20-day average of 21894481, indicating quieter trading ahead of this routine conference news. low

Technical Shares trade below the 200-day MA of 99.68, with the current price at 74.085, reflecting a longer-term downtrend into this event.

Peers on Argus

BSX is up 0.88% while peers show mixed moves: SYK +0.07%, MDT -0.25%, EW -3.59%,...

BSX is up 0.88% while peers show mixed moves: SYK +0.07%, MDT -0.25%, EW -3.59%, ABT -1.54%, PHG -2.54%. This pattern points to stock-specific positioning rather than a broad sector rotation.

Common Catalyst Several peers also released company-specific news (product clearance, conference participation), suggesting a news-heavy day for medical devices without a single unifying sector catalyst.

Historical Context

5 past events · Latest: 2026-02-04 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
2026-02-04	Earnings results	Positive	-17.6%	Strong Q4 and 2025 results with raised 2026 guidance and product approvals.
2026-01-15	Major acquisition	Neutral	-4.0%	Agreement to acquire Penumbra in a large cash-and-stock transaction.
2026-01-12	Bolt-on acquisition	Neutral	-2.0%	Agreement to acquire Valencia Technologies and its FDA-approved eCoin system.
2026-01-02	Conference & call	Neutral	-0.7%	J.P. Morgan conference appearance and scheduled Q4 and 2025 results call.
2025-12-10	Management & product	Neutral	+0.2%	CathVision board change and ECGenius System Version 3.5 commercial release.

Pattern Detected

Recent history shows a notable selloff on fundamentally strong earnings, while acquisition and conference headlines have driven only modest, generally aligned moves.

Recent Company History

Over the past few months, Boston Scientific has combined solid execution with active deal-making. On Feb 4, 2026, it reported strong Q4 and full-year 2025 results and raised 2026 guidance, yet the stock fell 17.59%. In January, it announced a $14.5 billion Penumbra acquisition and a smaller Valencia Technologies deal, both with limited share reaction. Earlier, participation in the J.P. Morgan Healthcare Conference and a CathVision-related update also produced muted moves. Today’s TD Cowen conference notice fits this pattern of routine investor-engagement news.

Market Pulse Summary

This announcement highlights Boston Scientific’s upcoming participation in TD Cowen’s health care co...

Analysis

This announcement highlights Boston Scientific’s upcoming participation in TD Cowen’s health care conference on March 3, 2026, featuring a 30-minute Q&A with senior leadership. It follows strong 2025 earnings, major M&A deals such as the $14.5 billion Penumbra agreement, and ongoing investor outreach like the J.P. Morgan conference. Investors may watch for any incremental commentary on integration, growth outlook, or capital allocation shared during the webcast.

AI-generated analysis. Not financial advice.

MARLBOROUGH, Mass., Feb. 13, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 46^th Annual Health Care Conference on Tuesday, March 3, 2026. Mike Mahoney, chairman and chief executive officer, and Kenneth Stein, M.D., senior vice president and global chief medical officer, will participate in a 30-minute question-and-answer session with the host analyst at approximately 9:10 a.m. ET.

A live webcast and replay of the session will be accessible at https://investors.bostonscientific.com. The replay will be available approximately one hour following the completion of the event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at www.bostonscientific.com and follow us on LinkedIn.  

CONTACTS:
Chanel Hastings
Media Relations
+1 (508) 382-0288
Chanel.Hastings@bsci.com

Lauren Tengler
Investor Relations
+1 (508) 683-4479
BSXInvestorRelations@bsci.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-td-cowens-46th-annual-health-care-conference-302687094.html

SOURCE Boston Scientific Corporation

FAQ

When will Boston Scientific (BSX) speak at TD Cowen's 46th Annual Health Care Conference?

Boston Scientific will speak on Tuesday, March 3, 2026 at approximately 9:10 a.m. ET. According to the company, the session is a 30-minute question-and-answer with the host analyst featuring senior executives.

Who from Boston Scientific (BSX) will present at the March 3, 2026 TD Cowen conference?

Mike Mahoney, chairman and CEO, and Kenneth Stein, M.D., senior VP and global chief medical officer, will present. According to the company, both executives will participate together in a 30-minute Q&A session with the host analyst.

How can investors watch Boston Scientific's (BSX) TD Cowen conference presentation on March 3, 2026?

A live webcast and replay will be accessible via the company's investor website. According to the company, the replay will be posted roughly one hour after the session concludes for on-demand viewing.

How long is Boston Scientific's (BSX) presentation at the TD Cowen conference on March 3, 2026?

The company scheduled a 30-minute question-and-answer session at about 9:10 a.m. ET. According to the company, the Q&A will feature two senior executives and be hosted by a TD Cowen analyst.

Will there be a replay of Boston Scientific's (BSX) TD Cowen session and when will it be available?

Yes. A replay will be available on the investor website approximately one hour after the event ends. According to the company, both a live webcast and the replay will be posted online for investors.